Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia
Phase of Trial: Phase II
Latest Information Update: 15 Oct 2017
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Primary progressive aphasia
- Focus Pharmacodynamics
- Acronyms SLD3
- 15 Oct 2017 Last checked against ClinicalTrials.gov record.
- 07 Mar 2017 Status changed from not yet recruiting to recruiting.
- 15 Apr 2016 New trial record